Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
JA Roberts, MH Abdul-Aziz, J Lipman… - The Lancet infectious …, 2014 - thelancet.com
Infections in critically ill patients are associated with persistently poor clinical outcomes.
These patients have severely altered and variable antibiotic pharmacokinetics and are …
These patients have severely altered and variable antibiotic pharmacokinetics and are …
Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
RP Veiga, JA Paiva - Critical Care, 2018 - Springer
Antimicrobials are among the most important and commonly prescribed drugs in the
management of critically ill patients and beta-lactams are the most common antibiotic class …
management of critically ill patients and beta-lactams are the most common antibiotic class …
A guide to therapeutic drug monitoring of β‐lactam antibiotics
AJ Fratoni, DP Nicolau, JL Kuti - Pharmacotherapy: The Journal …, 2021 - Wiley Online Library
Therapeutic drug monitoring (TDM) opens the door to personalized medicine, yet it is
infrequently applied to β‐lactam antibiotics, one of the most commonly prescribed drug …
infrequently applied to β‐lactam antibiotics, one of the most commonly prescribed drug …
Clinical implications of antibiotic pharmacokinetic principles in the critically ill
AA Udy, JA Roberts, J Lipman - Intensive care medicine, 2013 - Springer
Successful antibiotic therapy in the critically ill requires sufficient drug concentrations at the
site of infection that kill or suppress bacterial growth. The relationship between antibiotic …
site of infection that kill or suppress bacterial growth. The relationship between antibiotic …
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia
MH Kollef, J Chastre, M Clavel, MI Restrepo, B Michiels… - Critical Care, 2012 - Springer
Introduction The aim of this study was to compare a 7-day course of doripenem to a 10-day
course of imipenem-cilastatin for ventilator-associated pneumonia (VAP) due to Gram …
course of imipenem-cilastatin for ventilator-associated pneumonia (VAP) due to Gram …
Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients
Purpose Risk factors for β-lactam antibiotic underdosing in critically ill patients have not
been described in large-scale studies. The objective of this study was to describe …
been described in large-scale studies. The objective of this study was to describe …
Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France
B Lefèvre, L Tondeur, Y Madec, R Grant… - The Lancet Healthy …, 2021 - thelancet.com
Variants of SARS-CoV-2 have emerged that are more transmissible than the original virus or
that exhibit some properties of immune escape, or both. The beta (B. 1.351) variant has …
that exhibit some properties of immune escape, or both. The beta (B. 1.351) variant has …
Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?
IK Delattre, FS Taccone, F Jacobs, M Hites… - Expert review of anti …, 2017 - Taylor & Francis
Introduction: The pharmacokinetic/pharmacodynamic index determining β-lactam activity is
the percentage of the dosing interval (% T) during which their free serum concentration …
the percentage of the dosing interval (% T) during which their free serum concentration …
Optimizing antimicrobial drug dosing in critically ill patients
P Póvoa, P Moniz, JG Pereira, L Coelho - Microorganisms, 2021 - mdpi.com
A fundamental step in the successful management of sepsis and septic shock is early
empiric antimicrobial therapy. However, for this to be effective, several decisions must be …
empiric antimicrobial therapy. However, for this to be effective, several decisions must be …
What are the current approaches to optimising antimicrobial dosing in the intensive care unit?
Antimicrobial dosing in the intensive care unit (ICU) can be problematic due to various
challenges including unique physiological changes observed in critically ill patients and the …
challenges including unique physiological changes observed in critically ill patients and the …